Delivery Order SPE2DX15D3012-SPE2DX24F8VX5

Award Date 9/26/24
Potential Completion Date 10/18/24
Potential Value $11K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablet 30s, a specialty pharmaceutical product. The total ceiling value of the contract is $164,613.12, and it was awarded on May 22, 2024 with a completion date of June 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,641.07, is for the delivery of the prescription medication Tagrisso 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not associated with a set-aside program and represents open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tagrisso 80 mg tablets. The ceiling value of the contract is $21,077.60, and it is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Tagrisso 80 mg Tablet 30s. The $10,247.07 firm fixed-price delivery order has a completion date of December 12, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tagrisso 80 mg tablets. The $10,662.57 firm fixed-price delivery order has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $10,538.79, is a delivery order for the supply of the oncology drug Tagrisso (80 mg tablets). The contract is a firm fixed-price agreement and has a completion date of September 9, 2024. Amerisourcebergen is a significant supplier of pharmaceuticals and medical supplies to various government agencies, including the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm-fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a medical product. The contract has an ultimate completion date of April 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,538.79 firm-fixed-price contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a completion date of October 9, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,903.03, is for the delivery of the medication Tagrisso 80 mg tablets. This is a firm fixed-price delivery order contract with a completion date of January 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,247.06, is for the delivery of Tagrisso 80 mg tablets. It is a firm fixed-price delivery order contract with a completion date of May 18, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DX15D3012
    Indefinite Delivery Contract
  • SPE2DX15D3012-SPE2DX24F8VX5
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tagrisso 80 mg tablets. The contract has a ceiling value of $10,538.79 and runs through October 18, 2024. It is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation. Amerisourcebergen, through its extensive pharmaceutical and medical supply chain, will deliver the specified prescription drug to federal healthcare providers, including military treatment facilities and veterans' hospitals, to meet the medication needs of military personnel, veterans, and other government beneficiaries.

Generated 12/26/24, 9:28 AM